市場調查報告書
商品編碼
1426128
全球眼科器材市場評估:依產品、最終使用者、地區、機會、預測(2017-2031)Ophthalmic Equipment Market Assessment, By Product, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球眼科設備市場規模預計將從 2023 年的 554.9 億美元增至 2031 年的 813.6 億美元,2024-2031 年預測期間複合年增長率為 4.9%。我是。 老齡化人口的成長正在推動市場。 隨著年齡的增長,患有慢性疾病的人數也在增加。 白內障、老年黃斑部病變(AMD)和糖尿病視網膜病變等眼部疾病的高盛行率也是市場的主要驅動因素。 市場擴張也歸因於眼科手術數量和接受手術患者數量的增加。
此外,全球眼科設備市場受益於政府對尖端眼科手術設備研發的大量資助,以及該行業主要參與者推出的新型眼科治療設備。預計將獲得。 此外,肥胖率上升以及久坐和不活動的生活方式日益增加對眼科設備的需求。 低度全身性發炎與久坐的生活方式(SB)有關,並可能導致乾眼症(DED)的發生。 由於這些因素的綜合作用,全球眼科器械市場預計將顯著增長,其中北美由於人口迅速老化和慢性眼部病患疾病率上升而引領市場。
眼疾患率不斷上升
眼部疾病盛行率的增加大大促進了全球眼科器材市場的擴大成長。 全球至少有 22 億人患有近視或遠視。 視力障礙和失明的兩個最常見原因是白內障和屈光不正。 據估計,全世界只有 17% 由於白內障導致視力喪失的人以及 36% 由於屈光不正導致遠視力喪失的人得到了充分的治療。 視力障礙給世界帶來了巨大的經濟負擔,每年的生產損失估計達 4,110 億美元。 儘管所有年齡層的人都可能受到視力喪失的影響,但大多數失明或視力喪失的人都在 50 歲以上。
技術進步
技術進步正在推動全球眼科設備市場。 最近的技術發展有可能徹底改變全球眼科保健服務並減少可預防的失明。 由於全球眼科設備市場的技術進步,眾多鏡頭、物鏡、相機、超音波感測器、紅外線感測器、雷射感測器等的整合已成為可能。 驗光和眼科也受到人工智慧的影響。 目前,該技術還可用於建立圖表來追蹤老年黃斑部病變和黃斑水腫等狀況、識別病變、篩檢糖尿病視網膜病變以及追蹤某些疾病的進展。 儘管工具預計很快就會面世,但人工智慧目前正被用於診斷和預測眼部疾病以及隨著疾病進展估計視力的研究。
例如,2023 年 10 月,蔡司醫療技術與勃林格殷格翰簽署了一項長期策略協議,開發基於人工智慧的眼部疾病預測分析。 兩家公司將結合眼科技術、數據分析、演算法和治療開發的知識,儘早發現和治療視網膜疾病,避免永久視力喪失。
政府措施
世界各國政府已採取多項措施來支持眼科器材產業。 政府在研發上投入大量資金來開發最先進的眼科手術設備,以及市場主要參與者推出新的眼科疾病治療設備,預計將推動市場的發展。 政府增加醫療支出和升級醫療基礎設施的措施也推動了眼科設備市場的發展。 例如,印度政府衛生和家庭福利部發布的2021-2022年年度報告揭示了國家失明和視力障礙控制計劃(NPCBVI)中引入的變化。 該計劃將在國家衛生使命 (NHM) 的框架內提供初級/二級眼保健服務。 資金安排是中央政府和各州以60:40的比例分攤費用(東北部各州和其他山區州為90:10)。
本報告針對全球眼科設備市場進行研究和分析,提供市場規模和預測、市場動態、主要公司現狀和展望等。
Global ophthalmic equipment market is projected to witness a CAGR of 4.9% during the forecast period 2024-2031, growing from USD 55.49 billion in 2023 to USD 81.36 billion in 2031. The rising aging population drives the global ophthalmic equipment market. With increasing age, the tendency of people suffering from chronic diseases also increases. The high prevalence of eye conditions, such cataracts, age-related macular degeneration (AMD), and diabetic retinopathy, are acting as another major factor driving the global ophthalmic equipment market. The expansion of the global ophthalmic equipment market can also be attributed to the rising number of ophthalmic surgeries and the growing number of patients having surgical treatments.
Moreover, the global ophthalmic equipment market is anticipated to gain from significant government funding for R&D to create cutting-edge ophthalmic surgical equipment and from the introduction of novel eye disease treatment devices by major businesses in the sector. Additionally, driving the need for ophthalmic devices are the rising rates of obesity and the growing sedentary and inactive lifestyles. Low-grade systemic inflammation has been associated with sedentary behaviour (SB) and may contribute to the development of dry eye disease (DED). These factors combined are predicted to cause the global ophthalmic equipment market to grow significantly, with North America leading the market due to its rapidly ageing population and rising prevalence of chronic eye conditions.
Increasing Prevalence of Ocular Conditions
Rising prevalence of ocular conditions greatly contributes to increasing growth of global ophthalmic equipment market. At least 2.2 billion people worldwide suffer from a near- or far-sightedness. The two most common causes of visual impairment and blindness are cataracts and refractive errors. It is predicted that only 17% of individuals with cataract-related vision impairment and 36% of people with refractive error-related distant vision impairment have access to the right kind of intervention worldwide. A significant financial burden on the world is posed by vision impairment; the yearly cost of lost production is estimated to be USD 411 billion. Individuals of all ages can be affected by vision loss, but most of them who have blindness or vision impairment are over 50.
Technological Advancements
Advancements in technology are driving the global ophthalmic equipment market. Recent technology developments have the potential to revolutionise the provision of ophthalmic care globally and lower preventable blindness. The integration of many lenses, objectives, cameras, ultrasonic, infrared, and laser sensors, among other devices, has been made feasible by technological advancements in the global ophthalmic equipment market. Optometry and ophthalmology have also been affected by artificial intelligence (AI). As of right now, this technique can also be used to create graphs to follow pathologies like age-related macular degeneration or macular oedema, identify lesions, screen for diabetic retinopathy, and track the advancement of certain diseases. Although it is anticipated that tools will soon be available, AI is now being used to research diagnostic and predictive aspects for ocular illnesses, as well as the approximated calculation of visual acuity according to the disease's evolution.
For example, Zeiss Medical Technology and Boehringer Ingelheim signed a long-term strategic agreement in October 2023 to develop predictive analytics for eye illnesses using AI. The firms aim to pool their combined knowledge in ophthalmological technology, data analytics, algorithms, and therapy development to detect and treat retinal illnesses in their early stages and avert permanent vision loss.
Government Initiatives
Governments across the world are taking numerous initiatives to support the ophthalmic equipment industry. Significant government spending on R&D to create cutting-edge ophthalmic surgical equipment and the introduction of novel eye disease treatment devices by major companies in the market are anticipated to drive the market. Government measures to expand healthcare spending and upgrade healthcare infrastructure are also fueling the market for ophthalmic devices. For instance, 2021-22 Annual Report released by the Ministry of Health and Family Welfare, Government of India, reveals the changes that have been introduced to the National Programme for Control of Blindness and Visual Impairment (NPCBVI). The program will now offer primary and secondary eye care services within the National Health Mission (NHM) structure. The funding arrangement involves a 60:40 cost division between the Central Government and the State (90:10 in North-Eastern States and other hilly States).
The goal of the National Health Policy (NHP) is to bring the prevalence of blindness down to 0.25 percent by 2025. Grant-in-aid is primarily given for cataract operations, treatment/management of other eye diseases, eye banks and eye donation centres, free eyeglasses distribution to schoolchildren (to District Health Societies, DHSs), training of paramedical ophthalmic assistants (PMOAs), and other paramedics and upkeep of ophthalmic equipment.
Growing Demand for Femtosecond Laser
The increasing demand for femtosecond lasers has greatly contributed to the growth of the global ophthalmic equipment market. The primary factors contributing to this growth are the increasing number of cataract procedures across the globe, advances in laser technology, and the rising prevalence of eye illnesses like cataracts. Femtosecond lasers are primarily used to treat cataract, with their benefits mainly seen in femtosecond laser-assisted cataract surgery. These include standardised corneal incisions, precisely centred, circular capsulorhexis, and lens nucleus fragmentation-even in eyes with hard cataracts. The real-time OCT software programmes, which span the entire anterior segment up to the posterior lens capsule, are responsible for the laser's precision. Femtosecond lasers are extremely effective because they are precise, safe, and give patients the best possible visual outcomes.
For example, in June 2023, the highly anticipated release of VISUMAX 800 and Quatera 700, two of ZEISS's state-of-the-art medical devices in Bangladesh, was announced by the company, a global leader in optics and optoelectronic technology. A cutting-edge femtosecond laser platform, the VISUMAX 800 offers previously unheard-of safety and precision in a range of ophthalmic treatments.
Cataract Surgery Devices are Transforming the Market
Significant advancements and growing demand for cataract surgery devices are transforming the global ophthalmic equipment market. Devices, such as phacoemulsification machines, intraocular lenses (IOLs), and femtosecond lasers, provide more accurate and less invasive cataract removal methods. This change is in response to the increasing number of elderly people globally, who are more susceptible to cataracts. Additionally, improvements in IOLs, including multifocal and toric lenses, are enhancing the quality of vision after surgery, leading to higher patient satisfaction. The combination of these technological improvements, enhanced awareness, and greater accessibility is driving market expansion, making cataract surgery more efficient, safer, and easily accessible.
For example, the worldwide eye health business Johnson & Johnson Vision introduced the ELITA Femtosecond Laser vision correction in Korea on November 23, 2023, and the new TECNIS PureSee IOL for cataract surgery on the same day. TECNIS PureSee is a multi-focal intraocular lens that targets to improve both near and far vision, providing cataract patients with an opportunity to perform and enjoy everyday tasks, such as cooking, driving, and watching TV, without the need for reading glasses.
Future Market Scenario (2024-2031F)
The global ophthalmic equipment market has a very promising future, with substantial increase anticipated in the upcoming years. Key drivers for the anticipated expansion include the rising frequency of eye ailments, the expanding need for surgical and visual care devices, and the increasing prevalence of ocular conditions, including cataracts and glaucoma. The growing use of digital devices like laptops, computers, e-readers, and smartphones is also anticipated to help the industry, as these gadgets are predicted to drive the ophthalmic devices market.
In line with this, the global ophthalmic equipment market is growing because of various measures taken by governments worldwide to assist the ophthalmic equipment sector. Along with significant government funding for research and development to create cutting-edge ophthalmic surgical equipment, the market is anticipated to gain from the introduction of novel eye disease treatment devices by major players in the sector.
Key Players Landscape and Outlook
Companies in the global ophthalmic equipment market are merging and acquiring one another to broaden their range of products, improve their technological prowess, and obtain a competitive advantage. The need for new facilities to house the growing number of ophthalmology clinics, the rising incidence of eye problems, and the growing demand for sophisticated ophthalmic technology are the main drivers of these mergers and acquisitions. These businesses are concentrating on new product development, as well as ongoing research and development, to produce cutting-edge technology, which is spurring the expansion of the sector.
For example, in January 2023, the international contract research company TFS HealthScience announced that it strategically purchased Appletree CI Group to augment its current proficiency in the intricate domains of ophthalmology, dermatology, medical devices, and paediatric studies and broaden its clientele's geographic reach. Becoming a market leader in ophthalmic research is a goal that TFS HealthScience will further with the strategic purchase of Appletree.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work